Tight controls and focus on innovation provide strong outlook for Roche
This article was originally published in Scrip
Executive Summary
Taking Roche on the road to present its financial results is developing into a habit for CEO Severin Schwan, who brought his top team to London again on July 23rd to unveil another impressive performance from the world’s number five in pharma in ex-factory sales and clear number one in diagnostics.